CSIMarket
 


Zyla Life Sciences  (EGLT)
Other Ticker:  
 
 

EGLT's Revenue Growth by Quarter and Year

Zyla Life Sciences's Revenue results by quarter and year




EGLT Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -20.33 8.50 7.80
III Quarter September - 22.39 8.15 6.65
II Quarter June - 22.03 7.44 6.26
I Quarter March 19.07 6.26 6.26 5.43
FY   19.07 30.35 30.35 26.14



EGLT Revenue first quarter 2020 Y/Y Growth Comment
Zyla Life Sciences reported Revenue surge of 204.57% year on year in the first quarter 2020, to $ 19.07 millions, this is lower than Zyla Life Sciences's recent average Revenue surge of 221.7%.

Looking into first quarter 2020 results within Major Pharmaceutical Preparations industry 22 other companies have achieved higher Revenue growth. While Zyla Life Sciences' s Revenue doubling of 204.57% ranks overall at the positon no. 129 in the first quarter 2020.




EGLT Revenue ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - 8.97 % 27.04 %
III Quarter September - 174.72 % 22.56 % 41.19 %
II Quarter June - 196.1 % 18.85 % 81.45 %
I Quarter March 204.57 % 0 % 15.29 % 104.14 %
FY   - 0 % 16.11 % 54.13 %

Financial Statements
Zyla Life Sciences's first quarter 2020 Revenue $ 19.07 millions EGLT's Income Statement
Zyla Life Sciences's first quarter 2019 Revenue $ 6.26 millions Quarterly EGLT's Income Statement
New: More EGLT's historic Revenue Growth >>


EGLT Revenue (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - 4.29 % 17.29 %
III Quarter September - 1.63 % 9.54 % 6.23 %
II Quarter June - 251.92 % 18.85 % 15.29 %
I Quarter March - -26.35 % -19.74 % -11.56 %
FY (Year on Year)   - 0 % 16.11 % 54.13 %




Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #23
Healthcare Sector #41
Overall #129

Revenue Y/Y Growth Statistics
High Average Low
2240.58 % 221.7 % -68.32 %
(Dec 31 2015)  
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #23
Healthcare Sector #41
Overall #129
Revenue Y/Y Growth Statistics
High Average Low
2240.58 % 221.7 % -68.32 %
(Dec 31 2015)  

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Zyla Life Sciences's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EGLT's I. Quarter Q/Q Revenue Comment
This reversal of fortune I. Quarter 2020where Zyla Life Sciences delivered Revenue of $ 19.07 millions could be beginning of improved performance.Zyla Life Sciences announced in the I. Quarter 2020 Revenue of $ 19.07 millions compare to recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Zyla Life Sciences achieved highest sequential Revenue growth. While Zyla Life Sciences's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


EGLT's I. Quarter Q/Q Revenue Comment
This turnaround I. Quarter 2020where Zyla Life Sciences published Revenue of $ 19.07 millions should be considered as a inception of positive results.Zyla Life Sciences announced in the I. Quarter 2020 Revenue of $ 19.07 millions compare to recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Zyla Life Sciences achieved highest sequential Revenue growth. While Zyla Life Sciences's Revenue growth quarter on quarter, overall rank is .


Zyla Life Sciences's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 43.16 $ 30.35 $ 59.18 $ 44.94 $ 30.35
Y / Y Revenue Growth (TTM) 42.19 % 0 % 99.52 % 59.61 % 12.54 %
Year on Year Revenue Growth Overall Ranking # 407 # 2121 # 159 # 317 # 1155
Seqeuential Revenue Change (TTM) 42.19 % -48.71 % 31.67 % 48.07 % 0 %
Seq. Revenue Growth (TTM) Overall Ranking # 407 # 3349 # 146 # 98 # 2003




Cumulative Revenue growth Comment
Although Zyla Life Sciences's Annual Revenue growth year on year were below company's average 197.22% , Revenue announced in the Mar 31 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 42.19% year on year, from 0% in Dec 31 2019.

In the Healthcare sector 108 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 407, from total ranking in previous quarter at 2121.

Revenue TTM Q/Q Growth Statistics
High Average Low
1089.06 %
197.22 %
-25.69 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 109
Overall # 407

Revenue TTM Y/Y Growth Statistics
High Average Low
1089.06 %
197.22 %
-25.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 51
Sector # 106
S&P 500 # 407
Cumulative Revenue growth Comment
Although Zyla Life Sciences's Annual Revenue growth year on year were below company's average 197.22% , Revenue announced in the Mar 31 2020 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 42.19% year on year, from 0% in Dec 31 2019.

In the Healthcare sector 108 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 407, from total ranking in previous quarter at 2121.

Revenue TTM Q/Q Growth Statistics
High Average Low
1089.06 %
197.22 %
-25.69 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 51
Healthcare Sector # 109
Overall # 407

Revenue TTM Y/Y Growth Statistics
High Average Low
1089.06 %
197.22 %
-25.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 51
Sector # 106
S&P 500 # 407




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EGLT's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EGLT's Competitors
Revenue Growth for Zyla Life Sciences's Suppliers
Revenue Growth for EGLT's Customers

You may also want to know
EGLT's Annual Growth Rates EGLT's Profitability Ratios EGLT's Asset Turnover Ratio EGLT's Dividend Growth
EGLT's Roe EGLT's Valuation Ratios EGLT's Financial Strength Ratios EGLT's Dividend Payout Ratio
EGLT's Roa EGLT's Inventory Turnover Ratio EGLT's Growth Rates EGLT's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Rigel Pharmaceuticals Inc341.71%$ 341.706 millions
Immunitybio inc 320.00%$ 320.000 millions
Option Care Health Inc 294.20%$ 294.197 millions
Ainos Inc 272.91%$ 272.915 millions
Eyepoint Pharmaceuticals Inc 272.22%$ 272.217 millions
Theravance Biopharma inc 272.09%$ 272.087 millions
Elite Pharmaceuticals Inc 268.01%$ 268.010 millions
American Cryostem Corporation264.03%$ 264.034 millions
Chinook Therapeutics Inc 254.24%$ 254.241 millions
Voyager Therapeutics Inc 247.64%$ 247.643 millions
Aytu Biopharma Inc 243.01%$ 243.015 millions
Coherus Biosciences inc 213.17%$ 213.171 millions
Therapeuticsmd Inc 210.41%$ 210.406 millions
Harpoon Therapeutics Inc 210.16%$ 210.160 millions
Gw Pharmaceuticals Plc207.37%$ 207.369 millions
Zyla Life Sciences204.52%$ 204.520 millions
Verastem inc 202.57%$ 202.573 millions
Alnylam Pharmaceuticals Inc 198.78%$ 198.781 millions
Adma Biologics Inc 189.06%$ 189.060 millions
Agios Pharmaceuticals Inc 188.15%$ 188.146 millions
Healthlynked Corp 187.52%$ 187.520 millions
Editas Medicine Inc 176.61%$ 176.607 millions
Checkpoint Therapeutics inc 176.14%$ 176.136 millions
Albireo Pharma inc 171.75%$ 171.754 millions
Venus Concept Inc 168.97%$ 168.966 millions
Surface Oncology Inc 167.37%$ 167.369 millions
Aethlon Medical Inc 158.41%$ 158.411 millions
Inspiremd Inc 149.16%$ 149.157 millions
Cue Biopharma Inc 143.24%$ 143.243 millions
Palisade Bio Inc 140.80%$ 140.800 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com